blood, urine and anthropometric measures. 15 It represented 96.3% of the Canadian population aged 6 to 79 living at home and residing in the 10 provinces and 3 territories but excluded people living on reserves or other Aboriginal settlements, certain remote areas and institutions, and full-time members of the Canadian Forces. Data were collected from approximately 5,600 participants over a two-year period (2007) (2008) (2009) ) at 15 sites with a minimum of 500 respondents for each sex from five age groups (6 to 11, 12 to 19, 20 to 39, 40 to 59 and 60 to 79 years). Collection sites were stratified into five regions to achieve national representation. A household interview was conducted to obtain general demographic information and to administer an in-depth health questionnaire. A visit to a mobile examination centre (MEC) included physical measure tests and the collection of blood and urine samples. The study population for this analysis included women of childbearing age (15-49 years, n=1,369) with a valid red blood cell (RBC) folate value (n=1,320) who were not consuming a folic-acid-containing supplement (n=1,008) ( Figure 1 ).
Identification of non-users of folic acid supplements
Study participants were queried about drugs and supplements used in the 30 days before the date of the interview at the MEC. Drug Identification Numbers (DIN) and Natural Health Product Identification Numbers (NPN) were collected. The Anatomical Therapeutic Chemical (ATC) codes A11A, A11B, A11E, A11GB, A11J, B03AD, B03AE, B03BB and V03AF were used to identify potential folic-acid-containing supplements in the CHMS shared file database. The ATC codes were cross-referenced to the associated DINs and NPNs in the CHMS database by Statistics Canada. The list of DINs and NPNs was used to query the Drug Product Database 16 and the Licensed Natural Health Products Database 17 to determine the folic acid content of products used by CHMS participants.
Blood analyses
Hematocrit was measured in whole blood at the MEC. Whole blood was collected, processed and frozen; frozen blood samples were shipped to the Nutrition Research Division, Health Canada (Ottawa, ON), and stored at -20°C. Frozen whole-blood samples were thawed and diluted 1:26 with 0.5% ascorbic acid solution. Hemolysates stood for 180 minutes at room temperature. Folate was analyzed using the Immulite 2000 immunoassay (Siemens Canada, Mississauga), as described by the manufacturer. RBC folate was normalized to hematocrit. The cut-off for NTD protective folate status (906 nmol/L) was based on the relationship between RBC folate and NTD risk, as determined by the analysis of Daly et al. 
Demographic and lifestyle factors
Age groups for the analysis were 15-19, 20-39 and 40-49 years, or 15-24 and 25-49 years for the age-stratified multivariate analysis. Marital status was defined as currently in a relationship (married or common-law) or currently single (separated, divorced, widowed or single-never married). Education was defined as less than secondary, secondary education or some post-secondary, or completion of post-secondary education. Individuals with diabetes diagnosed by a physician (self-reported) or with glycated hemoglobin (HbA1C) ≥5.7% were identified as being at increased risk of hyperglycemia.
1816 Ethnicity, income adequacy, smoking and body mass index (BMI) were all derived variables in the CHMS dataset, which means that data from one variable were collapsed into categorical groupings (ethnicity, income adequacy, smoking) or were calculated using data from other variables (income adequacy, BMI). Ethnicity was defined as White or nonWhite, which included Aboriginals living off-reserve. Household income adequacy was calculated on the basis of both total family income from all sources and total number of household members, and defined as lowest, lower-middle or upper middle/highest income, with a fourth income category for individuals with missing data. Smoking status was defined as current non-smoker (combined former daily or occasional smoker and never-smoker) or current smoker (combined current daily or occasional smoker). Height and weight were measured at the MEC and used to calculate BMI. The BMI categories were defined as <18.5 (underweight), 18.5-24.99 (normal), 25-29.99 (overweight) and ≥30 (obese). Underweight and normal BMI categories were combined for analysis. Missing values for a given variable were excluded from calculations, except for income adequacy. Missing values for income adequacy represented nearly 10% of the sample and were therefore included as an additional category.
Statistics
The CHMS used a complex sampling design that allowed for nationally representative estimates. Because of the limited number of primary sampling units, Statistics Canada recommends that 11 degrees of freedom (df) be applied to all statistical analyses. 19 The 11 df result from the stratification of the Total CHMS sample N= ~5600
Women aged 15-49 y n=1369
Valid RBC folate n=1320
Non-users of folic acid supplements n=1008
15 primary sampling sites into 4 regions (Atlantic region was collapsed into the Quebec region for analysis). Prevalence estimates were calculated using data weighted to represent the Canadian population aged 6 to 79 years. Bootstrap weights and the 11 df were applied to all variance estimations of geometric means, proportions and regression parameters according to Statistics Canada protocols. As a result of the t distribution, Statistics Canada recommends the use of a t test to assess differences between means and proportions.
Multivariate logistic regression models were employed to assess adjusted odds ratios (ORs) for the independent association of socio-demographic and lifestyle factors with lower folate status. Marital status and hyperglycemia risk were not included in the age-stratified models because of the 11 df restriction on the number of parameters that could be included in a regression model and because of their non-significant association with lower folate status in the univariate analysis. The full model included age group, ethnicity, income adequacy, smoking and BMI. Education was not included in the full model because educational attainment is dependent on age in younger women. Two models stratified by age (15-24 and 25-49 years) included the same variables and education with age adjusted continuously. Statistical significance was defined as a p value ≤0.05. Analyses were performed using SAS Enterprise Guide 4 software (SAS Institute Inc., Cary, NC), BOOTVAR 3.2-SAS version (Statistics Canada, Ottawa, ON; available at http://www.statcan.gc.ca/rdccdr/bootvar_sas-eng.htm) and SUDAAN 10.0.1 (RTI International, Research Triangle Park, NC).
RESULTS
Of the Canadian women aged 15- Multivariate logistic regression models were employed to assess the independent associations of factors associated with an RBC folate <906 nmol/L (Table 2 ). In the full model, the adjusted OR for lower folate status tended to increase with decreasing age and income; however, only young age (adjusted OR 1.99, 95% CI: 1.25-3.18; p<0.01) was significantly associated with lower folate status. We also considered models stratified by age that included women aged 15-24 or women aged 25-49 years ( 
DISCUSSION
Low folate status is a risk factor for NTDs. 3 A number of sociodemographic and lifestyle factors have been associated with low folate status or inadequate folic acid intake. The CHMS, cycle 1, provided an opportunity to identify socio-demographic and lifestyle factors associated with lower folate status in a nationally representative sample of Canadian women exposed to foods fortified with folic acid. We specifically excluded women taking folic-acid-containing supplements, 24 Table 1 .
Median 20 This allowed us to focus on women exposed only to natural or synthetic food-derived folate.
We found that the majority of Canadian women, 76.4%, have an RBC folate value greater than 906 nmol/L. Univariate analysis identified numerous factors associated with RBC folate <906 nmol/L in non-supplement-consuming women, including age, ethnicity, education, income adequacy, smoking and BMI. Interestingly, we did not observe an association between hyperglycemia risk and folate status. Maternal hyperglycemia and diabetes during pregnancy have been associated with increased risk of NTDs, 21 and it has been suggested that women with these conditions may benefit from high-dose folic acid supplementation. 22 Our data indicate that the folate status of women at risk for hyperglycemia, as indicated by high HbA1c or self-reported diabetes, does not differ from that of women with normal HbA1c or that did not report diabetes; however, it is not clear whether folate metabolism may be altered or folate requirements increased in the diabetic state.
Multivariate logistic regression analysis found that after adjustment for ethnicity, income adequacy, smoking and BMI, only young age (15-19 years), which has previously been associated with increased NTD risk, 23 was significantly associated with lower folate status. Using two age-stratified models, we observed an association between having less than a secondary education and lower folate status among young women aged 15-24. One potential caveat to this finding is that some women in the 15-24 year age group may not have completed secondary school simply because of their younger age. While we controlled for age continuously to mitigate the effect of age on education, this finding may remain difficult to interpret. Among women aged 25-49, we found that lowest household income adequacy was associated with lower folate status, whereas education was not. Low socio-economic status has previously been associated with an increased NTD risk. 23, 24 These data indicate that not all women benefit equally from mandatory folic acid fortification and that specific subgroups of women remain at higher risk of lower folate status and NTDs. The different age-associated risk profiles for lower folate status may depend on a number of factors. For instance, there may be fundamental differences in folate requirements or dietary patterns among younger and older women: younger Canadian women score lower on the Healthy Eating Index and are more likely to consume food prepared in fast-food outlets than older Canadian women. 25 In women aged 25-49 years, the association of lowest income adequacy with increased risk of lower folate status suggests that these women are vulnerable to lower folate status despite fortification. They may have a poorer diet resulting in a lower consumption of food that is naturally rich in folate, such as fresh vegetables, or less folic acid enriched foods than women of higher income adequacy. It is known that Canadians with low household income and education have lower scores for the Healthy Eating Index, and fewer of them eat the recommended number of vegetables and fruit. 25 These differences could be due to economic limitations or food insecurity in women with low income adequacy.
The strengths of this study include the nationally representative sample and a population-based sampling strategy. Limitations of the analysis are the lack of reliable estimates for dietary folate intake, low power to detect associations between folate status and some factors and the use of a dichotomous cutoff for assessing folate-dependent NTD risk. While the 906 nmol/L value has been used extensively in the literature to assess NTD risk, it is not a recognized cut-off. Daly et al. demonstrated that women with an RBC folate value of ≥906 mol/L had the lowest NTD risk in their study population. 3 However, the relationship between RBC folate and NTD risk demonstrated a non-linear negative association. 3 The prevalence of folate deficiency among Canadian women is <1%, 26 and >90% have an RBC folate >680 nmol/L, 27 a value that was associated with a ~75% lower NTD risk compared with the NTD risk of women with an RBC value ≤339 nmol/L in the Daly model. direct comparison between the Immulite assay and the microbiological assay used by Daly et al. has not been published, therefore a correction factor has not been calculated to allow for direct comparisons between data produced by one or the other assay.
CONCLUSIONS
Overall, our data indicate that the association of many sociodemographic and lifestyle factors with lower folate status in the pre-fortification period has been mitigated in a population exposed to folic acid through fortified foods. Nevertheless, nearly 25% of non-supplement-consuming Canadian women have a folate status that may not provide optimal NTD protection, and specific groups of women remain at increased risk of NTDs despite exposure to a fortified food supply. Health Canada and the Public Health Agency of Canada recommend that women who could become pregnant take a daily multivitamin supplement containing 0.4 mg folic acid to decrease their NTD risk. Modelling has shown that folic acid supplement consumption at this dose does not pose a risk of folic acid intakes above the Tolerable Upper Intake Level, in contrast to doses greater than 0.4-0.6 mg. 11, 30 It seems prudent to continue to promote this recommendation with the acknowledgement that the Canadian women at increased risk of lower folate status are also those who are less likely to consume folic acid supplements in the periconceptional period. [31] [32] [33] Our data present a challenge to public health officials to craft folic acid supplementation recommendations that specifically target these consistently vulnerable groups.
